DE3579113D1 - Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. - Google Patents

Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.

Info

Publication number
DE3579113D1
DE3579113D1 DE8585902080T DE3579113T DE3579113D1 DE 3579113 D1 DE3579113 D1 DE 3579113D1 DE 8585902080 T DE8585902080 T DE 8585902080T DE 3579113 T DE3579113 T DE 3579113T DE 3579113 D1 DE3579113 D1 DE 3579113D1
Authority
DE
Germany
Prior art keywords
arthric
diseases
compositions
determination
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585902080T
Other languages
English (en)
Inventor
Lawson Stanford
Robert Cohen
Ayala Frenkel
Joseph Holoshitz
Eden Willem Van
Arthur Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
University College London
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London, Yeda Research and Development Co Ltd filed Critical University College London
Application granted granted Critical
Publication of DE3579113D1 publication Critical patent/DE3579113D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DE8585902080T 1984-04-27 1985-04-29 Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. Expired - Lifetime DE3579113D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL71683A IL71683A0 (en) 1984-04-27 1984-04-27 Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
PCT/GB1985/000183 WO1985005034A1 (en) 1984-04-27 1985-04-29 Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions

Publications (1)

Publication Number Publication Date
DE3579113D1 true DE3579113D1 (de) 1990-09-13

Family

ID=11055018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585902080T Expired - Lifetime DE3579113D1 (de) 1984-04-27 1985-04-29 Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.

Country Status (7)

Country Link
US (1) US4716038A (de)
EP (1) EP0181364B1 (de)
JP (1) JPH0751509B2 (de)
AU (1) AU588809B2 (de)
DE (1) DE3579113D1 (de)
IL (1) IL71683A0 (de)
WO (1) WO1985005034A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
US5268170A (en) * 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
EP0419569B1 (de) * 1988-06-15 1995-09-06 Whitehead Institute For Biomedical Research Stressproteine und verwendungen dafür
US5780034A (en) * 1989-03-14 1998-07-14 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents
US5578303A (en) * 1989-03-14 1996-11-26 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use
CA2065744A1 (en) * 1989-08-23 1991-02-24 Zvi Fuks Wound healing preparations containing heparanase
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
DK0556248T3 (da) * 1990-11-08 1997-10-27 Univ London Mycobacterium som adjuvans til antigener
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
DK0700445T3 (da) 1993-06-04 2002-05-13 Whitehead Biomedical Inst Stressproteiner og anvendelser deraf
WO1995028642A1 (en) 1994-04-14 1995-10-26 Brown, Keith, Edwin, Frank A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US7157089B1 (en) 1996-11-26 2007-01-02 Stressgen Biotechnologies Corporation Immune responses using compositions containing stress proteins
CN1129453C (zh) * 1996-12-18 2003-12-03 斯坦福鲁克有限公司 用于下调免疫系统Th2活性的母牛分枝杆菌
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
WO1998035705A1 (en) * 1997-02-18 1998-08-20 Whitehead Institute For Biomedical Research Use of heat shock proteins to deliver moieties into cells
JP2001519785A (ja) * 1997-04-02 2001-10-23 バイオニケ ライフ サイエンシーズ インコーポレイテッド 局所的障害および創傷の治療のための細菌細胞壁抽出物の使用
ES2266652T3 (es) * 1997-08-05 2007-03-01 Stressgen Biotechnologies Corporation Respuestas inmunologicas contra los antigenos de hpv provocadas por compuestos que contienen un antigeno de hpv y una proteina de stress o un vector de expresion capaz de expresar dichas proteinas.
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
EP0947524A1 (de) * 1998-03-30 1999-10-06 Upither B.V. Neue Peptide zur Behandlung von Autoimmunkrankheiten
CA2354047C (en) * 1998-12-04 2007-08-14 Bioniche Life Sciences Inc. Method for the treatment of inflammation
US6497880B1 (en) * 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
US6638518B1 (en) * 1999-02-22 2003-10-28 University Of Iowa Research Foundation Method for inhibiting inflammatory responses
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
US20040247622A1 (en) * 1999-06-02 2004-12-09 Genesis Research And Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
CA2378097A1 (en) 1999-07-08 2001-01-18 Stressgen Biotechnologies Corporation Induction of a th1-like response in vitro
AU6896300A (en) * 1999-08-06 2001-03-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
CA2396384A1 (en) 2000-01-14 2001-07-19 Whitehead Institute For Biomedical Research In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
EE200200709A (et) 2000-06-26 2004-08-16 Stressgen Biotechnologies Corporation Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
JP2005505238A (ja) 2001-02-05 2005-02-24 ストレスゲン バイオテクノロジーズ コーポレイション Ｂ型肝炎ウイルスの治療法
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
EP1684803B1 (de) * 2003-11-14 2010-07-07 UCL Business PLC Immunmodulator mit ganzzell-tsukamurella bakterien
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184531B1 (de) * 1972-05-19 1975-10-17 Anvar
GB1516507A (en) * 1974-06-20 1978-07-05 Anvar Process for obtaining mycobacterial fractions with anti-tumor anti-viral and adjuvant activities and pharmaceutical compositions containing them
FR2487198A1 (fr) * 1980-07-28 1982-01-29 Berri Balzac Sa Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations

Also Published As

Publication number Publication date
JPS61502258A (ja) 1986-10-09
EP0181364A1 (de) 1986-05-21
AU4297685A (en) 1985-11-28
WO1985005034A1 (en) 1985-11-21
US4716038A (en) 1987-12-29
JPH0751509B2 (ja) 1995-06-05
AU588809B2 (en) 1989-09-28
IL71683A0 (en) 1984-09-30
EP0181364B1 (de) 1990-08-08

Similar Documents

Publication Publication Date Title
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
ATE33098T1 (de) Celiprolol zur behandlung von glaukom.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
DE3770184D1 (de) Behandlung von gasstroemen.
DE3777861D1 (de) Behandlung von gasen.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3483330D1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE3777878D1 (de) Mittel zur verhinderung des zusammenbackens von duengemitteln.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE3785555D1 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
DE68908404D1 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
ATE55252T1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: STANFORD ROOK LTD., LONDON, GB

8339 Ceased/non-payment of the annual fee